Recruiting soon

ASKidsAgenda-setting Tool for Multidisciplinary Meetings in Pediatric Hospital Stays

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Structured Agenda-Setting Tool

Other
Who is being recruted

Over 7 Years
See all eligibility criteria
How is the trial designed

Services Research Study

Interventional
Study Start: May 2026
See protocol details

Summary

Principal SponsorDartmouth-Hitchcock Medical Center
Study ContactCatherine H. Saunders, PhD, MPHMore contacts
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2026

Actual date on which the first participant was enrolled.

This study focuses on improving the experience of children and their families during complex hospital stays. Researchers are testing a new tool called the Structured Agenda-setting (SAS) tool, which aims to help families and healthcare teams communicate better during hospital meetings. This tool is being tested in the pediatric department, where children are admitted for care. The goal is to see if this tool can make hospital stays less stressful and more effective for families by ensuring everyone is on the same page regarding the child's care. Participants in this study will use the SAS tool during their hospital stay. The study will look at how well the tool works by evaluating how it is used and whether it helps improve communication between families and healthcare teams. Researchers will also check if their methods for selecting participants and using questionnaires to gather feedback are effective. The results from this initial pilot study will help shape future, larger studies to further explore the benefits of the SAS tool in pediatric care. There are no specific risks mentioned, but the study aims to find ways to make hospital experiences more positive for families.

Official TitleCentering Children and Care Partners in Complex Pediatric Hospital Stays: Evaluation of a Structured Inpatient Agenda-setting Intervention for Multidisciplinary Family Meetings 
NCT07127666
Principal SponsorDartmouth-Hitchcock Medical Center
Study ContactCatherine H. Saunders, PhD, MPHMore contacts
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

20 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Services Research Study

These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 7 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

Inclusion Criteria: * Pediatric Inpatients: Children aged 7-17 years * Can communicate in English * Able to provide verbal assent, with consent from their care partner * Dartmouth Hitchcock Medical Center pediatric patient who currently or has recently (within the last 3 months) been hospitalized with a length of stay of 4≥ days Care Partners: - Adults aged 18≥ years * Can communicate in English * Able to provide verbal consent * Care partners of Dartmouth Hitchcock Medical Center pediatric patients who are currently or have recently (within the last 3 months) been hospitalized with a length of stay of 4≥ days Exclusion Criteria: * For pediatric inpatients, children \< aged 7 * For care partners, children aged \<18 years * Cannot communicate in English * For pediatric inpatients, unable to provide verbal assent * For care partners, unable to provide consent * Prisoners

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
The study team will implement a structured clinical visit agenda-setting (SAS) intervention customized for the pediatric inpatient environment.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Dartmouth Hitchcock

Lebanon, United StatesSee the location
Recruiting soonOne Study Center